瘤亚型,PPARγ表达和脂肪增殖之间的相互作用影响了乳腺癌的结果
Aditya Shah1,2, Katie Liu1,3, Ryan Liu1,4
1Departments of Cellular & Molecular Physiology, Internal Medicine (Endocrinology), and Comparative Medicine, Yale University, New Haven, Connecticut, USA.
Physiological reports
|November 14, 2025
概括
高PPARγ基因表达与更好的乳腺癌存活率相关,特别是在绝经前妇女中. 脂肪组织代谢也因瘤亚型和更年期状态而异,为精准医学提供了洞察力.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 代谢研究研究 代谢研究
背景情况:
- 乳腺癌的进展是复杂的,受瘤生物学,患者特征 (如更年期状态) 和代谢瘤微环境的影响.
- 在乳腺癌预后中PPARγ (氧酶增殖器激活受体马) 的作用及其与患者因素的相互作用仍然不完全理解.
研究的目的:
- 调查不同亚组的乳腺癌患者中PPARγ基因表达的预后意义.
- 检查与乳腺癌亚型和患者更年期状态有关的脂肪组织增殖和代谢活性.
主要方法:
- 从TCGA-BRCA队列中分析RNA测序数据,以将PPARγ表达与整体存活率相关联,按更年期状态和瘤受体亚型分层.
- 利用PET-CT成像数据 (ACRIN-6888试验) 测量脂肪组织中的18F-FLT吸收,以评估增殖,根据更年期状态和瘤亚型进行分析.
主要成果:
- 高PPARγ表达与改善整体存活率有关,特别是在绝经前乳腺癌患者中.
- 绝经后的女性表现出较低的内脏脂肪组织代谢活性 (18F-FLT SUV平均值).
- 雌激素受体阳性 (ER+) 或非三阴性乳腺癌 (非TNBC) 亚型显示脂肪组织增殖减少 (18F-FLT SUVpeak和SUVmax),表明亚型特定的脂肪组织重编程.
结论:
- 根据瘤亚型和更年期状态,PPARγ表达和脂肪组织增殖似乎对乳腺癌存活率产生不同影响.
- 这些发现突出了PPARγ作为潜在的治疗点,并强调了在精确治疗乳腺癌时考虑代谢因素的重要性.
相关概念视频
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
01:19Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K